Ultra Pharmaceuticals has sold the rights to injectables Restylane , Perlane , Emervel , Sculptra and Dysport to Galderma for $ 1.4bn . The sale was previously agreed with Nestlé , which recently acquired Galderma . Beginning July 28, Galderma will have a new branded distribution process. Ultra Classic and Ultra Ultra are currently awaiting approval from the US Food and Drug Administration and Health Canada .
Ultra Pharmaceuticals has sold the rights to injectables Restylane , Perlane , Emervel , Sculptra and Dysport to Galderma for $ 1.4bn . The sale was previously agreed with Nestlé , which recently acquired Galderma . Ultra Classic and Ultra Ultra are currently awaiting approval from the US Food and Drug Administration and Health Canada .